Molecular therapy. Methods & clinical development

CRISPR-Cas9 fixes a gene mutation to restore lebercilin protein and its placement in lab-grown human retinal tissue

Updated

Abstract

Mutations in the lebercilin-encoding gene are associated with one of the most severe forms of Leber congenital amaurosis.

  • A patient-specific cellular model was generated using CRISPR-Cas9 technology to correct a homozygous nonsense variant in patient-derived induced pluripotent stem cells.
  • Whole-genome sequencing demonstrated the absence of off-target editing in the gene-corrected control cells.
  • Differentiation of the patient, gene-corrected, and unrelated control iPSCs into three-dimensional retina-like cells revealed opsin and rhodopsin mislocalization in patient-derived organoids.
  • Lebercilin expression and localization along the ciliary axoneme were rescued in the gene-corrected organoids.

Simplified

Full Text

We can’t show the full text here under this license.

Funding

Competing interests

The authors declare that they have no conflict of interest related to the content of this manuscript.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free